(19/02/2023)vs
SALFO | 00 | 2 | 0 / 00% | 1 / 425% | 0 / 10% | 1 / 520% | | 3 | 10 | 4 | 14 | 1 | 1 | 3 | 2 | 15 |
(12/02/2023)vs
NEW MED | 00 | 2 | 0 / 00% | 1 / 425% | 0 / 00% | 1 / 425% | | 2 | 5 | 2 | 7 | 2 | 0 | 1 | 0 | 9 |
(29/01/2023)vs
ΑΣΤΡΟΝ ΧΗΜΙΚΑ | 32 | 2 | 0 / 00% | 1 / 520% | 0 / 10% | 1 / 616.7% | | 1 | 8 | 4 | 12 | 2 | 2 | 2 | 2 | 13 |
(15/01/2023)vs
HEALTHCARE | 25 | 8 | 2 / 540% | 3 / 475% | 0 / 00% | 3 / 475% | | 1 | 6 | 2 | 8 | 1 | 1 | 1 | 3 | 12 |
(08/01/2023)vs
ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ ΣΑΛΒΑΡΑ | 00 | 6 | 2 / 2100% | 2 / 450% | 0 / 10% | 2 / 540% | | 1 | 8 | 4 | 12 | 3 | 0 | 1 | 5 | 14 |
(18/12/2022)vs
ΑΜΥΝΤΑΣ BC | 29 | 7 | 0 / 00% | 2 / 633.3% | 1 / 1100% | 3 / 742.9% | | 3 | 7 | 1 | 8 | 3 | 0 | 1 | 0 | 15 |
(12/11/2022)vs
SALFO | 36 | 6 | 0 / 00% | 3 / 933.3% | 0 / 20% | 3 / 1127.3% | | 3 | 13 | 1 | 14 | 3 | 1 | 4 | 2 | 18 |
(06/11/2022)vs
ΑΣΤΡΟΝ ΧΗΜΙΚΑ | 29 | 4 | 2 / 450% | 1 / 520% | 0 / 10% | 1 / 616.7% | | 2 | 7 | 3 | 10 | 3 | 0 | 2 | 1 | 11 |
(23/10/2022)vs
BST / NIGICO | 28 | 7 | 2 / 2100% | 1 / 520% | 1 / 1100% | 2 / 633.3% | | 2 | 6 | 3 | 9 | 1 | 1 | 2 | 2 | 14 |
(16/10/2022)vs
NEW MED | 00 | 7 | 1 / 250% | 3 / 742.9% | 0 / 10% | 3 / 837.5% | | 2 | 12 | 1 | 13 | 4 | 2 | 2 | 1 | 21 |
(08/10/2022)vs
LP CLINIC | 27 | 7 | 3 / 475% | 2 / 633.3% | 0 / 10% | 2 / 728.6% | | 1 | 6 | 3 | 9 | 1 | 0 | 0 | 1 | 10 |
| ΣΥΝΟΛΙΚΑ |
206 |
58 |
12 / 1963.2% |
20 / 5933.9% |
2 / 1020% |
22 / 6931.9% |
|
21 |
88 |
28 |
116 |
24 |
8 |
19 |
19 |
152 |
| ΜΕΣΟΙ ΟΡΟΙ |
18.7 |
5.3 |
1.1 / 1.763.2% |
1.8 / 5.433.9% |
0.2 / 0.920% |
2 / 6.331.9% |
|
1.9 |
8 |
2.5 |
10.5 |
2.2 |
0.7 |
1.7 |
1.7 |
13.8 |